EU Medicines Agency updates procedural guidance in line with new pharmacovigilance legislation

Susan Najjar

The European Medicines Agency has revised its procedural guidance for pharmaceutical companies to include the latest information related to the new pharmacovigilance legislation. The guidance for applicants covers pre- and post-authorisation procedures. There are also specific sections for generic, hybrid and biosimilar medicines.

Read More.